-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 15, Yuandong Biological announced that its self-developed Class 1 new drug Eudagliptin Tablets (hereinafter referred to as "Udagliptin Tablets") is being used as a single drug for the treatment of type 2 diabetes mellitus in China that is poorly controlled by simple diet and exercise.
In the large-scale phase III clinical study of patients, the first subject has been successfully enrolled for administration recently
.
Eudagliptin is a dipeptidyl peptidase-IV (DPP-4) inhibitor, which has good hypoglycemic effect and excellent safety, and has been gradually accepted by clinicians and patients
.
Eudagliptin Tablets is a new class 1 chemical drug independently developed by the company and is the first oral DPP-4-week preparation for the treatment of type 2 diabetes in China